A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
Clinical trial NCT04988087 · TERMINATED
Trial details
- NCT number
- NCT04988087
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-02-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.